Parkinson's disease (PD) is a chronic, progressive neurodegenerative disorder that affects movement, muscle control, and balance. It is part of a group of conditions known as motor system disorders, which are the result of the loss of dopamine-producing brain cells.
The exact cause of PD is unknown, but it is thought to involve both genetic and environmental factors. Pathologically, PD is characterized by the degeneration of dopaminergic neurons in the substantia nigra pars compacta and the presence of Lewy bodies, which are protein aggregates that develop inside nerve cells.
PD typically presents with motor symptoms such as bradykinesia, rigidity, tremor, and postural instability. However, non-motor symptoms like autonomic dysfunction, cognitive impairment, and mood disorders can also occur and significantly impact the quality of life.
Diagnosis of PD is primarily clinical, based on the presence of characteristic motor symptoms and the response to dopaminergic therapy. Neuroimaging can be used to rule out other conditions but is not typically required for diagnosis.
Treatment for PD is symptomatic, aiming to improve the quality of life by controlling symptoms. Pharmacological treatment primarily involves the use of dopaminergic medications. Non-pharmacological interventions, such as physical therapy and occupational therapy, are also crucial components of management.
PD is a progressive disease with no cure. The rate of progression varies widely among individuals. While PD itself is not fatal, complications can be serious and include falls, choking, and pneumonia.
Understanding Parkinson's disease involves a comprehensive approach, taking into account its complex pathophysiology, diverse clinical presentation, and the importance of a multidisciplinary approach to treatment. Continued research into the underlying mechanisms and potential treatments is crucial for improving the lives of those affected by this challenging condition.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation